Efficacy of azithromycin, clarithromycin and β-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 3, 2001, Pages 425-430

  Miyazaki, S ^a   Fujikawa, T ^a   Matsumoto, T ^a   Tateda, K ^a   Yamaguchi, K ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFCAPENE; CEFCAPENE PIVOXIL; CEFDINIR; CLARITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BRONCHOPNEUMONIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG HALF LIFE; HAEMOPHILUS INFLUENZAE; LUNG; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BETA-LACTAMS; BRONCHOPNEUMONIA; CLARITHROMYCIN; DISEASE MODELS, ANIMAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; MALE; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; TREATMENT OUTCOME;

EID: 0034812605     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to ampicillin-clavulanate: Surveillance study
2. Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I-results from the SENTRY antimicrobial surveillance program (North America, 1998)
3. Increasing prevalence of ampicillin-resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan
4. Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens
5. The other mediator for adherence of Haemophilus influenzae organisms without involvement of fimbriae
6. New murine model of bronchopneumonia due to cell-bound Haemophilus influenzae
7. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, ceftamet and loracarbef
8. Cloning and expression of genes responsible for altered penicillin-binding proteins 3a and 3b in Haemophilus influenzae
9. Cefuroxime treatment failure of nontypeable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins
10. Mechanisms of resistance of an ampicillin-resistant, β-lactamase-negative clinical isolate of Haemophilus influenzae type b to β-lactam antibiotics
11. Haemophilus influenzae adheres to and enters cultured human epithelial cells
12. Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay
13. Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infection
14. Serum and cellular pharmacokinetics of clarithromycin 500 mg o.d. and 250 mg b.i.d. in volunteers
15. Pharmacokinetics of azithromycin in patients with impaired hepatic function
16. Azithromycin concentrations at the sites of pulmonary infection
17. Intrapulmonary pharmacokinetics of clarithromycin and of azithromycin
18. In vitro and in vivo antibacterial activity of S-1108, a new ester form oral cephem antibiotic (abstract in English)
19. Therapeutic effect of oral levofloxacin, ciprofloxacin, and ampicillin on experimental murine pneumonia caused by penicillin intermediate Streptococcus pneumoniae for which the minimum inhibitory concentrations are similar
20. Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA
21. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
22. Opsonizing and bactericidal effects of normal human serum on nontypeable Haemophilus influenzae
23. Post-antibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens
24. Ketolide treatment of Haemophilus influenzae experimental pneumonia
25. Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans